IP Library Granted Patent US 9,486,270
Granted Patent B2
US 9,486,270 · App. 14/816,115 · Granted Nov 8, 2016

Methods and apparatus for bilateral renal neuromodulation

Inventors: Denise Zarins (Saratoga, CA); Hanson Gifford, III (Woodside, CA); Mark Deem (Mountain View, CA); Douglas Sutton (Pacifica, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61B18/12A61B18/14A61B18/1492A61M5/1408A61N1/0412A61N1/05A61N1/0551A61N1/327A61N1/36007A61N1/36017A61B2018/00267A61B2018/00434A61B2018/00577A61M5/14276A61M2210/1082A61N7/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,486,270
App. No.
14/816,115
Granted
Nov 8, 2016
Kind
B2
Abstract

Methods and apparatus are provided for bilateral renal neuromodulation, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

Claims (44)

1. A method for renal neuromodulation of a human patient, the method comprising:

delivering a first ultrasound to neural fibers disposed adjacent a first renal blood vessel and innervating a first kidney, wherein the first ultrasound inhibits neural traffic along the neural fibers innervating the first kidney; and

delivering a second ultrasound to neural fibers disposed adjacent a second renal blood vessel and innervating a second kidney, wherein the second ultrasound inhibits neural traffic along the neural fibers innervating the second kidney,

wherein inhibiting neural traffic along the neural fibers innervating the first kidney and the neural fibers innervating the second kidney results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient.

2. The method of claim 1 wherein the first ultrasound is the same as the second ultrasound.

3. The method of claim 1 wherein the first ultrasound is a high frequency ultrasound.

4. The method of claim 1 further comprising:

positioning a first catheter within the first renal blood vessel of the patient and proximate to the neural fibers innervating the first kidney of the patient;

wherein the first ultrasound is delivered via the first catheter.

5. The method of claim 4 further comprising:

positioning a second catheter within the second renal blood vessel of the patient and proximate to the neural fibers innervating the second kidney of the patient;

wherein the second ultrasound is delivered via the second catheter.

6. The method of claim 5 , further comprising removing the first catheter from the first renal blood vessel of the patient before positioning the second catheter within the second renal blood vessel of the patient.

7. The method of claim 5 wherein positioning the first catheter within the first renal blood vessel of the patient and positioning the second catheter within the second renal blood vessel of the patient occur simultaneously.

8. The method of claim 5 wherein:

positioning the first catheter within the first renal blood vessel of the patient comprises intravascularly delivering the first catheter to the first renal blood vessel over a first guidewire; and

positioning the second catheter within the second renal blood vessel of the patient comprises intravascularly delivering the second catheter to the second renal blood vessel over a second guidewire.

9. The method of claim 1 wherein:

inhibiting neural communication along the neural fibers innervating the first kidney comprises ablating the neural fibers innervating the first kidney; and

inhibiting neural communication along the neural fibers innervating the second kidney comprises ablating the neural fibers innervating the second kidney.

10. The method of claim 1 wherein:

inhibiting neural communication along the neural fibers innervating the first kidney comprises denervating the first kidney of the patient; and

inhibiting neural communication along the neural fibers innervating the second kidney comprises denervating the second kidney of the patient.

11. The method of claim 1 wherein:

inhibiting neural communication along the neural fibers innervating the first kidney comprises reducing renal sympathetic nerve activity of the first kidney; and

inhibiting neural communication along the neural fibers innervating the second kidney comprises reducing renal sympathetic nerve activity of the second kidney.

12. A method for catheter-based renal denervation of a human patient, the method comprising:

intravascularly positioning a catheter within a first renal artery associated with a first kidney of the patient;

at least partially ablating nerves along the first renal artery via a first ultrasound from the catheter;

intravascularly positioning the catheter within a second renal artery associated with a second kidney of the patient; and

at least partially ablating nerves along the second renal artery via a second ultrasound from the catheter,

wherein at least partially ablating the nerves along the first renal artery and the nerves along the second renal artery results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient.

13. The method of claim 12 , further comprising removing the catheter from the patient after delivering the first and second ultrasounds to conclude the procedure.

14. The method of claim 12 wherein at least partially ablating the nerves along the first renal artery and the nerves along the second renal artery results in a therapeutically beneficial reduction in blood pressure in the patient.

15. The method of claim 12 wherein the first and second ultrasounds are both high frequency ultrasounds.

16. A method for catheter-based renal denervation of a human patient, the method comprising:

intravascularly positioning a catheter within a first renal artery associated with a first kidney of the patient;

at least partially ablating nerves along the first renal artery via a first ultrasound from the catheter;

intravascularly positioning the catheter within a second renal artery associated with a second kidney of the patient; and

at least partially ablating nerves along the second renal artery via a second ultrasound from the catheter,

wherein at least partially ablating the nerves along the first renal artery and the nerves along the second renal artery results in a therapeutically beneficial reduction in blood pressure of the patient.

17. The method of claim 16 , further comprising removing the catheter from the patient after at least partially ablating nerves along the first and second renal arteries via the first and second ultrasounds, to conclude the procedure.

18. The method of claim 16 wherein at least partially ablating the nerves along the first renal artery and the nerves along the second renal artery results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient.

19. The method of claim 16 wherein the first and second ultrasounds are both high frequency ultrasounds.

Continuity (24)
Continuation 14260060 · Apr 23, 2014
Continuation 14034434 · Sep 23, 2013
Continuation 13361685 · Jan 30, 2012
Division 11368836 · Mar 6, 2006
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11133925 · May 20, 2005
Continuation 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11363867 · Feb 27, 2006
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11129765 · May 13, 2005
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60813589 · Dec 29, 2005
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60624793 · Nov 2, 2004
Related Publication 20160030736A1 · Feb 4, 2016